Table 2.
System description/substrate | Cell type | Medium/supplements | SF 1 | CD 2 | XF 3 | Culture period | Ref |
---|---|---|---|---|---|---|---|
Synthetic acrylate surfaces (PAS) with peptides: Vitronectin, bone sialo protein | hESC | X -VIVO 10 | Y | N | Y | >10 passages | [89] |
bFGF,TGF-β1 | |||||||
Activin A | |||||||
Synthemax 4 | hiPSC | mTeSR1 | Y | N | N | 10 passages | [90] |
Synthemax 4 | hESC | mTESR1 | Y | N | N | 10–20 passages | [91] |
hiPSC | TESR2 | Y | Y | Y | |||
PSGro | Y | Y | Y | ||||
Nutristem XF | Y | N | Y | ||||
PMEDSAH 5 coated plates | hESC | MEF-CM6 | N | N | N | 25 passages | [98] |
hCCM7 | N | N | Y | ||||
StemPro, | Y | N | N | ||||
mTeSR | Y | N | N | ||||
Alkanethiol with heparin binding proteins | hESC | mTeSR1 | Y | N | N | >17 passages | [92] |
Rock inhibitor | |||||||
PMVE-alt-MA 8 | hiPSC | StemPro | Y | N | N | 5 passages | [94] |
APMAAm 9 hydrogels | hESC | mTeSR1 | Y | N | N | 20 passages | [95] |
Polyethylene glycol hydrogels (PEG) | hESC | DMEM/F12 + KSR | N | N | N | 9 days | [118] |
bFGF | |||||||
Hillex 10 microcarrier//suspension culture | hESC | KSR-XF 10 | Y | N | Y | 6–14 days | [123] |
BRASTEM, | Y | N | Y | ||||
bFGF |
1SF serum –free medium.
2CD chemically defined medium (excludes any media containing BSA or HSA fraction due to their unknown and variable composition).
3XF xeno-free, no animal components in medium or culture system.
4Synthemax acrylate surface coated with peptide derived from vitronectin.
5PMEDSAH Poly [2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide]—.
6MEF-CM mouse embryonic fibroblast conditioned medium.
7Human cell conditioned medium.
8PMVE-alt-MA poly (methyl vinyl ether-alt-maleic anhydride.
9APMAAm aminopropylmethacrylamide—.
10Hillex polystyrene beads modified with cationic trimethyl ammonium.